October 1, 2014
There is a reason why some generic drugs come on the market faster than others and it's a practice the Obama Administration is fighting all the way to the Supreme Court.
The so-called Pay-for-Delay deals between large pharmaceutical companies and generic drug competitors keep the lower priced drugs on the shelf for years sometimes.
Regulators claim the practice denies consumers price declines on many common drugs. Their estimate is that it costs consumers nearly $3 Billion per year.